This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.

The Effect of Curcumin on the Clinical Outcome of Pediatric Patients with Active Lupus Nephritis | MicrobiomeTrials

NCT05714670

The Effect of Curcumin on the Clinical Outcome of Pediatric Patients with Active Lupus Nephritis

CompletedPHASE2INTERVENTIONAL

Trial Details

Start: 2023-04-01Est. Completion: 2023-10-01

Enrollment target: 72 participants

Locations

Outpatients Clinic of Pediatric Rheumatology department - Children's Hospital, Ain Shams University, Cairo, Egypt., Cairo, Egypt

Systemic Lupus Erythematosus (SLE)

In this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with systemic…

Phoenix, United StatesCompleted Mar 29, 2030

LupusSystemic Lupus ErythematosusLupus Nephritis

This study will assess how mosunetuzumab works in people who have systemic lupus erythematosus (SLE) who may or may not …

Salvador, BrazilEst. completion Feb 28, 2028

Systemic Lupus ErythematosusLupus Nephritis

The study is intended to assess safety, efficacy and cellular kinetics of YTB323 treatment in participants with severe r…

Clayton, AustraliaEst. completion Sep 24, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.